| Recruiting | 4 | 335 | Europe, Canada, US, RoW | Stopping Heart Failure Medication(s) | University Health Network, Toronto, Unity Health Toronto, Hamilton Health Sciences Corporation, St. Boniface Hospital, University of Alberta, University of Ottawa Heart Institute, Canada, University College London Hospitals, Alberta Health Services, Calgary, Brigham and Women's Hospital, Baker Heart and Diabetes Institute | Heart Failure, Cardiotoxicity, Cardiac Toxicity, Antineoplastics Toxicity, Cancer | 12/27 | 12/31 | | |
| Recruiting | N/A | 45000 | Canada | Diagnostic testing performed as per routine care | University of Calgary, Alberta Health services | Cardiovascular Diseases | 08/25 | 08/30 | | |
FLICOR, NCT05250791: Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome |
|
|
| Recruiting | N/A | 50 | Europe | Lidocaine hydrochloride 2% for injection, Xylocaine, 0.9% sterile Sodium Chloride solution for injection, Saline | Imperial College London | Colorectal Cancer, Quality of Life, Recurrent Cancer | 09/24 | 09/24 | | |